Ibandronsyre 2, 5 mg administreret dagligt resulterede i en statistisk signifikant og medicinsk relevant reduktion i forekomsten af nye vertebrale frakturer.
Efficacy was evaluated in 2,928 patients. ibandronic acid 2.5 mg administered daily, showed a statistically significant and medically relevant reduction in the incidence of new vertebral fractures.